Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study

.

Source: Expert Opinion on Biological Therapy - December 18, 2023 Category: Drugs & Pharmacology Authors: A ChiricozziSM FerrucciL Di NardoN GoriA BalatoM OrtoncelliM MaurelliM GalluzzoM Munera CamposT SeremetG CaldarolaC De SimoneE IppolitiT TorresS GkalpakiotisC ConradJM CarrascosaL BianchiG ArgenzianoS RiberoG GirolomoniAV MarzanoK Perisa Dermatologia, Dip Source Type: research